On March 14, 2016, Pharma Tech Solutions, Inc. and Decision IT Corp. (“Plaintiffs”) filed a complaint against Lifescan, Inc., Lifescan Scotland, Ltd. and Johnson and Johnson (“Defendants”) asserting infringement of U.S. Patent Nos. 6,153,069 (“the ‘069 Patent”) and 6,413,411 (“the ‘411 Patent”). The ‘069 Patent and the ‘411 Patent are both assigned to Decision IT Corp., with Pharma Tech Solutions, Inc. as the exclusive licensee. The ‘069 Patent and the ‘411 Patent are drawn to a method and apparatus for amperometric diagnostic analysis. The Plaintiffs are asserting that the Defendants are infringing the ‘069 Patent and the ‘411 Patent by making, using, importing, exporting, offering to sell, and selling their One Touch Ultra blood glucose test strips and meters. The case remains pending and is captioned 2-16-cv-00564.
By: Jacqueline A. DiRamio